Entrez Id: |
6885 |
Gene Symbol: |
MAP3K7 |
MAP3K7
|
Forney Robinson Pascoe syndrome
|
0.710 |
Biomarker |
GENOMICS_ENGLAND |
Mutations in MAP3K7 that Alter the Activity of the TAK1 Signaling Complex Cause Frontometaphyseal Dysplasia.
|
27426733 |
2016 |
Entrez Id: |
6885 |
Gene Symbol: |
MAP3K7 |
MAP3K7
|
Forney Robinson Pascoe syndrome
|
0.710 |
GermlineCausalMutation |
ORPHANET |
Heterozygous Mutations in MAP3K7, Encoding TGF-β-Activated Kinase 1, Cause Cardiospondylocarpofacial Syndrome.
|
27426734 |
2016 |
Entrez Id: |
6885 |
Gene Symbol: |
MAP3K7 |
MAP3K7
|
Forney Robinson Pascoe syndrome
|
0.710 |
GeneticVariation |
UNIPROT |
Heterozygous Mutations in MAP3K7, Encoding TGF-β-Activated Kinase 1, Cause Cardiospondylocarpofacial Syndrome.
|
27426734 |
2016 |
Entrez Id: |
6885 |
Gene Symbol: |
MAP3K7 |
MAP3K7
|
Forney Robinson Pascoe syndrome
|
0.710 |
Biomarker |
CTD_human |
|
|
|
Entrez Id: |
6885 |
Gene Symbol: |
MAP3K7 |
MAP3K7
|
FRONTOMETAPHYSEAL DYSPLASIA 2
|
0.610 |
Biomarker |
GENOMICS_ENGLAND |
Which genes to assess in the NGS diagnostics of intellectual disability? The case for a consensus database-driven and expert-curated approach.
|
30914295 |
2019 |
Entrez Id: |
6885 |
Gene Symbol: |
MAP3K7 |
MAP3K7
|
Frontometaphyseal dysplasia
|
0.610 |
GermlineCausalMutation |
ORPHANET |
Mutations in MAP3K7 that Alter the Activity of the TAK1 Signaling Complex Cause Frontometaphyseal Dysplasia.
|
27426733 |
2016 |
Entrez Id: |
6885 |
Gene Symbol: |
MAP3K7 |
MAP3K7
|
FRONTOMETAPHYSEAL DYSPLASIA 2
|
0.610 |
GeneticVariation |
UNIPROT |
Mutations in MAP3K7 that Alter the Activity of the TAK1 Signaling Complex Cause Frontometaphyseal Dysplasia.
|
27426733 |
2016 |
Entrez Id: |
6885 |
Gene Symbol: |
MAP3K7 |
MAP3K7
|
FRONTOMETAPHYSEAL DYSPLASIA 2
|
0.610 |
Biomarker |
GENOMICS_ENGLAND |
Mutations in MAP3K7 that Alter the Activity of the TAK1 Signaling Complex Cause Frontometaphyseal Dysplasia.
|
27426733 |
2016 |
Entrez Id: |
6885 |
Gene Symbol: |
MAP3K7 |
MAP3K7
|
FRONTOMETAPHYSEAL DYSPLASIA 2
|
0.610 |
Biomarker |
GENOMICS_ENGLAND |
Frontometaphyseal dysplasia and keloid formation without FLNA mutations.
|
25899317 |
2015 |
Entrez Id: |
6885 |
Gene Symbol: |
MAP3K7 |
MAP3K7
|
Frontometaphyseal dysplasia
|
0.610 |
Biomarker |
CTD_human |
|
|
|
Entrez Id: |
6885 |
Gene Symbol: |
MAP3K7 |
MAP3K7
|
Frontometaphyseal dysplasia
|
0.610 |
Biomarker |
GENOMICS_ENGLAND |
|
|
|
Entrez Id: |
6885 |
Gene Symbol: |
MAP3K7 |
MAP3K7
|
Malignant neoplasm of prostate
|
0.330 |
Biomarker |
CTD_human |
Global analysis of differentially expressed genes in androgen-independent prostate cancer.
|
17199135 |
2007 |
Entrez Id: |
6885 |
Gene Symbol: |
MAP3K7 |
MAP3K7
|
Cholestasis, Extrahepatic
|
0.300 |
Biomarker |
CTD_human |
Hepatoprotective activities of rosmarinic acid against extrahepatic cholestasis in rats.
|
28789951 |
2017 |
Entrez Id: |
6885 |
Gene Symbol: |
MAP3K7 |
MAP3K7
|
FRONTOMETAPHYSEAL DYSPLASIA 1
|
0.300 |
Biomarker |
GENOMICS_ENGLAND |
These findings show that dysregulation of the TAK1 complex produces a close phenocopy of FMD caused by FLNA mutations.
|
27426733 |
2016 |
Entrez Id: |
6885 |
Gene Symbol: |
MAP3K7 |
MAP3K7
|
Prostatic Neoplasms
|
0.300 |
Biomarker |
CTD_human |
Global analysis of differentially expressed genes in androgen-independent prostate cancer.
|
17199135 |
2007 |